- Report
- February 2025
- 85 Pages
India
From €3107EUR$3,500USD£2,709GBP
- Report
- December 2024
- 85 Pages
India
From €3107EUR$3,500USD£2,709GBP
- Report
- April 2021
China
From €2308EUR$2,600USD£2,012GBP
- Report
- November 2018
- 30 Pages
China
From €1953EUR$2,200USD£1,703GBP
- Report
- July 2024
- 150 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Report
- November 2023
- 30 Pages
Global
From €2441EUR$2,750USD£2,128GBP
- Report
- October 2024
- 200 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Report
- May 2024
- 200 Pages
Global
From €3684EUR$4,150USD£3,212GBP
- Report
- March 2024
- 200 Pages
Global
From €3684EUR$4,150USD£3,212GBP
- Report
- March 2024
- 200 Pages
Global
From €3684EUR$4,150USD£3,212GBP
- Report
- August 2023
- 145 Pages
Global
From €2796EUR$3,150USD£2,438GBP
- Report
- August 2024
- 150 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Report
- July 2024
- 100 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Report
- July 2024
- 150 Pages
Global
From €3329EUR$3,750USD£2,902GBP
- Report
- June 2024
- 200 Pages
Global
From €7057EUR$7,950USD£6,153GBP
- Report
- February 2024
- 30 Pages
Global
From €2885EUR$3,250USD£2,515GBP
- Report
- January 2024
- 189 Pages
Global
From €6657EUR$7,500USD£5,804GBP
- Report
- November 2023
- 30 Pages
Global
From €2441EUR$2,750USD£2,128GBP
- Report
- November 2023
- 30 Pages
Global
From €2441EUR$2,750USD£2,128GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more